Macrolide antibacterials. Drug interactions of clinical significance.
about
Role of cytochrome P450 in drug interactionsClinical and financial impact of intravenous erythromycin therapy in hospitalized patients.Summary of information on human CYP enzymes: human P450 metabolism data.Syncopal episodes associated with cisapride and concurrent drugs.Lack of pharmacokinetic interaction between tiagabine and erythromycin.Review and comparison of advanced-generation macrolides clarithromycin and dirithromycin.Metabolism-based drug interactions involving oral azole antifungals in humans.Review article: cardiac adverse effects of gastrointestinal prokinetics.Macrolide - induced clinically relevant drug interactions with cytochrome P-450A (CYP) 3A4: an update focused on clarithromycin, azithromycin and dirithromycinSystemic sclerosis and bilateral lung transplantation: a single centre experienceEffects of erythromycin on voriconazole pharmacokinetics and association with CYP2C19 polymorphismRational prescription of drugs within similar therapeutic or structural class for gastrointestinal disease treatment: drug metabolism and its related interactions.Ketolides: an emerging treatment for macrolide-resistant respiratory infections, focusing on S. pneumoniae.Management of the pediatric liver transplant patient.Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors.Clinically relevant drug interactions with antiepileptic drugsDrug bioactivation, covalent binding to target proteins and toxicity relevance.Macrolides in cystic fibrosis.Drug interactions during therapy with three major groups of antimicrobial agents.Treatment and dosing of Helicobacter pylori infection: when pharmacology meets clinic.Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.Psychotropic drug-drug interactions involving P-glycoprotein.Autophagy in blood cancers: biological role and therapeutic implications.Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis.The clinical significance of drug interactions between dermatological and psychoactive medications.No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers.Macrolide therapy in chronic inflammatory diseases.Infection and inflammation leading to clozapine toxicity and intensive care: a case series.Torsade de pointes induced by cisapride/clarithromycin interaction.Digoxin toxicity secondary to clarithromycin therapy.Effect of levofloxacin on theophylline clearance during theophylline and clarithromycin combination therapy.Interaction between piroxicam and azithromycin during distribution to human periodontal tissues.Possible interaction between intravenous azithromycin and oral cyclosporine.Bradycardia associated with intravenous methadone administered for sedation in a patient with acute respiratory distress syndrome.The effect of erythromycin on the pharmacokinetics of rosuvastatin.Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions.A comparison of in vitro ADME properties and pharmacokinetics of azithromycin and selected 15-membered ring macrolides in rodents.Short-term clarithromycin administration impairs clearance and enhances pharmacodynamic effects of trazodone but not of zolpidem.
P2860
Q21245066-28C40712-E157-4780-81C0-91E2036D0626Q30736637-C23D81C0-2387-4A18-910A-B8FADC992185Q32103802-5B6D479B-B027-43E1-AE26-D36B1D3FA481Q33175671-05E8E27C-F59B-426A-8ADE-AE032A75C29BQ33488034-3ABD4EA9-C402-4CE1-A802-7CBE41624AB3Q33598839-6682E43F-D9EB-44C6-9718-E5290066D913Q33719828-6AE6FAAC-55AC-4A66-8653-D5D5A2586D24Q33792373-F31EA47D-BCDA-4CB1-95A9-1D62776AA58AQ34049823-85BE5650-6658-438C-B859-5172B9414C48Q34065448-FC051F6E-0314-4E35-A04D-8A4E75863F25Q34213621-EC7642A8-770B-4BB6-8ED2-9797C6C1EA51Q34233142-B203BA1D-B287-415E-9179-E2BF5E988CE1Q34281970-2CF48B23-8A6D-47F1-90A7-DDFDED7B1B82Q34426415-8FE49D5B-27CE-49CA-8F56-32BB9D5EB18FQ34429206-FADAF1C8-E354-4DBC-BCCA-2AA705D21D58Q35827491-DC5172DB-BB9B-44D3-A73C-ABF8660B4A6CQ36061821-C746903F-8ABC-41B2-A68F-92B508A67061Q36309930-715244EC-9A7E-4A0D-A7BC-72425AA98132Q36429699-D5CC08C2-30B1-4A7A-9EF8-C593192BDCFCQ36723844-3E5913CB-3F92-461E-BDFA-9F872660017DQ36871056-8322A078-C454-46ED-B2EC-114902E63EC6Q38047816-99F93017-8A66-4C3A-ACDF-72EDACD224DCQ38134372-678CDC0A-07A4-4E73-AA4A-3DECBEF72B85Q38178836-7E083C74-F5C1-4B29-8279-4D7F36A6D6CAQ38185684-942D648D-733D-45A2-B768-6B5B961B3F8CQ41921748-0751BC84-6578-449B-BEC1-78067E91E7BAQ42016590-37E10A40-FA70-4F57-B11F-EC3946C4FDD1Q42224496-F360BEF7-9CA5-42CC-B088-B357ACB26E42Q42536187-B628217E-CCBC-4077-8D7D-EE777194CC1CQ42548736-19E0E559-0A58-4764-AE76-618234B6EB11Q43642327-A3F37A4F-BA6C-4799-82E4-E59E56C8A9A3Q43751462-85272699-00DF-4C40-8AE7-1F1A491A078FQ43803090-9A67EC6F-6F95-4707-AC65-3D5BB94BE371Q44131818-1AC35291-D12D-4378-90BF-EE3BA6E85596Q44395020-80918E32-9BA7-48E1-85D3-A8811F27D5CDQ45069532-4945C25E-C3C8-4C89-9092-21214FD9D735Q45718671-66E28713-1CB1-4C7E-AC48-98A635718DC5Q46109640-33F7637A-7EF3-4493-AC97-2F0C310B5BB0
P2860
Macrolide antibacterials. Drug interactions of clinical significance.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Macrolide antibacterials. Drug interactions of clinical significance.
@en
type
label
Macrolide antibacterials. Drug interactions of clinical significance.
@en
prefLabel
Macrolide antibacterials. Drug interactions of clinical significance.
@en
P1433
P1476
Macrolide antibacterials. Drug interactions of clinical significance.
@en
P2093
N A von Rosensteil
P304
P356
10.2165/00002018-199513020-00005
P577
1995-08-01T00:00:00Z
P6179
1034530251